stockportfolio.pro
Stocks / ACAD vs IRTC
ACAD vs IRTC
ACADIA Pharmaceuticals Inc. and iRhythm Holdings, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| ACADIA Pharmaceuticals Inc. (ACAD) | iRhythm Holdings, Inc. (IRTC) | |
|---|---|---|
| Market cap | $3.7B | $3.7B |
| Revenue (latest FY) | $1.07B | $747.14M |
| Net income (latest FY) | $391.00M | $-44.55M |
| Revenue growth (5y CAGR) | 19.4% | 23.0% |
| Net margin | 36.5% | -6.0% |
| Return on equity | 31.9% | -29.2% |
| P/E ratio | 9.7 | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 2 | 0 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ACAD — free Open IRTC — freeFrequently asked questions
Which is bigger, ACAD or IRTC?
ACADIA Pharmaceuticals Inc. is larger by market capitalization — $3.7B versus $3.7B.
Which grows faster, ACAD or IRTC?
Over the last five fiscal years, iRhythm Holdings, Inc. grew revenue faster — 23.0%/yr versus 19.4%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.